MedPath
HSA Approval

SNUP STADA® SPRAY 0.1%

SIN15198P

SNUP STADA® SPRAY 0.1%

SNUP STADA® SPRAY 0.1%

March 23, 2017

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SPRAY

NASAL

Medical Information

R01AA07

xylometazoline

Manufacturer Information

DCH AURIGA SINGAPORE

Ursapharm Arzneimittel GmbH

Active Ingredients

Xylometazoline Hydrochloride 0.1%

0.100g

Xylometazoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SNUP STADA® SPRAY 0.1% - HSA Approval | MedPath